Benzinga's Top Upgrades

By: via Benzinga
Analysts at Morgan Stanley upgraded Infinity Pharmaceuticals Inc. (NASDAQ: INFI) from Equal-weight to Overweight. The price target ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.